JD Esq - 908 Devices Chief Secretary

908 Devices Management Efficiency

The company has return on total asset (ROA) of (0.1675) % which means that it has lost $0.1675 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5156) %, meaning that it created substantial loss on money invested by shareholders. 908 Devices' management efficiency ratios could be used to measure how well 908 Devices manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.6 in 2025. Return On Capital Employed is likely to gain to -0.54 in 2025. At this time, 908 Devices' Total Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 207.8 M in 2025, whereas Other Assets are likely to drop slightly above 962.9 K in 2025.

Similar Executives

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts. 908 Devices operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 177 people. 908 Devices (MASS) is traded on NASDAQ Exchange in USA. It is located in 645 Summer Street, Boston, MA, United States, 02210 and employs 246 people. 908 Devices is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

908 Devices Leadership Team

908 Stock Performance Indicators

Additional Tools for 908 Stock Analysis